AKT1 and cholangiocarcinoma: Recent studies have found the link between LTβR signaling and oncogenic protein kinase B, also named as AKT, in hepatitis and liver tumorigenesis, demonstrating that the activation of LTβR rapidly accelerates the intrahepatic cholangiocarcinoma progression initiated by the AKT/Notch signaling pathway [7].